Scipher Medicine and Kythera Labs Join Forces to Advance Autoimmune Disease Treatment In a groundbreaking move aimed at advancing precision medicine in the realm of autoimmune diseases, Scipher Medicine, a…
Click Therapeutics Secures FDA Approval for First-Ever Prescription Digital Migraine Therapy In a significant milestone for digital health and the millions of people affected by migraine disorders, Click Therapeutics, Inc.…
n-Lorem Foundation Celebrates Five Years of Innovation for Nano-Rare Diseases In an era where access to highly specialized medical treatments is often hindered by costs, timelines, and logistical constraints, the…
Eyestem’s Eyecyte-RPE™ Demonstrates Vision Preservation in Geographic Atrophy Clinical Trial Bangalore-based biotech firm Eyestem Research has reported highly encouraging results from its Phase 1 clinical trial evaluating Eyecyte-RPE™, a novel…
Atelerix Partners with MineBio to Distribute Cell Preservation Solutions in China UK-based biotech innovator Atelerix partners with MineBio to bring next-generation ambient-temperature cell preservation to the world’s fastest-growing biopharma market.…
Nuclera Enhances eProtein Platform to Support Membrane Protein Production Nuclera, a leading biotechnology innovator specializing in rapid protein expression and optimization, today announced a significant enhancement to its flagship benchtop…
Spectrum Vascular Appoints New Executive Leadership Team Spectrum Vascular, a fast-growing provider of vascular access and medication management products designed to reduce healthcare-associated infections (HAIs), has announced the appointment of…
ATED Therapeutics Develops Quick and Easy Blood Test for Detecting Parkinson’s Disease In a significant stride toward revolutionizing the diagnosis and monitoring of Parkinson’s disease (PD), UK-based biotech company ATED…
Soleo Health Named Exclusive Specialty Pharmacy for Qfitlia™ in Hemophilia Treatment Bringing a first-in-class antithrombin-lowering therapy to patients with hemophilia A or B, Soleo Health reinforces its leadership in specialty…
IPUMP Enhances Compliance in SLIT Treatment Stallergenes Greer, a global leader in allergy diagnostics and immunotherapy, has announced that it will present compelling findings from its SPEED survey at the…
Aulos Bioscience Begins Phase 2 Dosing of AU-007 and Nivolumab Combo for Melanoma Immuno-oncology innovator Aulos Bioscience has initiated dosing in a new cohort of its ongoing Phase 1/2 clinical…
Mirum Receives FDA Approval for Tablet Version of LIVMARLI In a significant advancement for the rare liver disease community, Mirum Pharmaceuticals, Inc. announced today that the U.S. Food and Drug…